Immune Regulation News Volume 12.44 | Nov 20 2020

    0
    122







    IRN 12.44 | Nov 20 2020


    Immune Regulation News by STEMCELL Technologies
    Vol. 12.44 – 20 November, 2020
    TOP STORY

    CD25-Treg-Depleting
    Antibodies Preserving IL-2 Signaling on Effector T Cells Enhance Effector Activation and Antitumor Immunity

    Scientists demonstrated potent single-agent activity of anti-CD25 antibodies optimized to deplete Treg cells, while preserving IL-2-STAT5 signaling on effector T cells and showed synergy with immune checkpoint blockade in vivo.
    [Nature Cancer]

    AbstractPress Release

    New human primary cell products—frozen leukopaks, regulatory T cells, and more. Click to view products.
    PUBLICATIONSRanked by the impact factor of the journal

    Small-Molecule-Induced Polymerization Triggers Degradation of BCL6

    Researchers report an alternative mechanism of targeted protein degradation, in which a small molecule induced the highly specific, reversible polymerization of a target protein, followed by its sequestration into cellular foci and subsequent degradation.
    [Nature]

    Full Article

    Protein
    Prenylation Drives Discrete Signaling Programs for the Differentiation and Maintenance of Effector Treg Cells

    Investigators showed that isoprenoid-dependent posttranslational lipid modifications dictated effector regulatory T cell accumulation and function by intersecting with T cell receptor-induced intracellular signaling.
    [Cell Metabolism]

    AbstractGraphical Abstract
    Press Release

    Competition
    for Active TGFβ Cytokine Allows for Selective Retention of Antigen-Specific Tissue- Resident Memory T Cells in the Epidermal Niche

    The authors found that the source of transforming growth factor-β-supporting resident memory T cells was autocrine.
    [Immunity]

    Abstract
    Graphical Abstract

    Senescent Cells Promote Tissue NAD+
    Decline during Aging via the Activation of CD38+ Macrophages

    Researchers showed that pro-inflammatory M1-like macrophages, but not naive or M2 macrophages, accumulate in metabolic tissues, including visceral white adipose tissue and liver, during ageing and acute responses to inflammation.
    [Nature Metabolism]

    Abstract
    Press Release

    CD38 Ecto-Enzyme in Immune Cells Is Induced during Aging and Regulates NAD+
    and NMN Levels

    Scientists showed that an increase in CD38 in white adipose tissue and the liver during aging was mediated by accumulation of CD38+ immune cells. Inflammation increased CD38 and decreased NAD+.
    [Nature Metabolism]

    Abstract
    Press Release

    Endothelial
    p300 Promotes Portal Hypertension and Hepatic Fibrosis through CCL2-Mediated Angiocrine Signaling

    In vitro, epigenome‐editing of carbon tetrachloride (CCL2) enhancer and promoter regions by CRISPR‐dCas9‐KRAB technology repressed TNFα‐induced CCL2 transcription via H3K9 tri‐methylation.
    [Hepatology]

    Abstract

    Cellular Context of IL-33 Expression Dictates Impact on Anti-Helminth Immunity

    Scientists demonstrated that cell-intrinsic IL-33 promoted mouse dendritic cells to express the pore-forming protein perforin-2, which may function as a conduit on the plasma membrane facilitating IL-33 export.
    [Science Immunology]

    Abstract
    Press Release

    Characterisation of CD4+
    T-Cell Subtypes Using Single Cell RNA Sequencing and the Impact of Cell Number and Sequencing Depth

    The authors found that the reparative macrophage transition was dictated by B-cell adapter for PI3K (BCAP). Mice harboring a macrophage-specific deletion of BCAP fail to recover from and succumb to dextran sulfate sodium-induced colitis due to prolonged intestinal inflammation and impaired tissue repair.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    Targeted
    Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity

    Recruitment of myeloid-derived suppressor cells into the tumor microenvironment contributes to cancer immune evasion. Scientists compared the growth and metastasis of melanoma and breast cancer xenografts in mice exhibiting or not exhibiting targeted deletion of Cxcr2 in myeloid cells.
    [Cancer Immunology Research]

    Abstract

    CSF1R
    Inhibition Depletes Tumor-Associated Macrophages and Attenuates Tumor Progression in a Mouse Sonic Hedgehog-Medulloblastoma Model

    By combining longitudinal manganese-enhanced magnetic resonance imaging and immune profiling of a sporadic mouse model of sonic hedgehog subgroup of medulloblastoma, researchers found the density of tumor-associated macrophages/microglia was higher in the ~50% of tumors that progress to lethal disease.
    [Oncogene]

    Abstract

    Platelet PD-L1 Suppresses Anti-Cancer Immune Cell Activity in PD-L1 Negative Tumors

    Investigators showed that platelet-derived programmed cell death protein-1 (PD-L1) regulated the growth of PD-L1 negative tumors and that interference with platelet binding to PD-L1 negative cancer cells promoted T cell-induced cancer cytotoxicity.
    [Scientific Reports]

    Full Article

    Request a copy of the COVID-19 wallchart.
    REVIEWS

    Macrophage Metabolic Reprogramming during Chronic Lung Disease

    The authors focus on how metabolic alterations underlie airway macrophage phenotype and function during chronic lung diseases.
    [Mucosal Immunology]

    Full Article

    INDUSTRY AND POLICY NEWS


    Proteintech
    and HebeCell Announce Collaboration on Nanobody iPSC-derived Natural Killer Cells

    Proteintech and HebeCell announced their collaborative partnership to develop proprietary nanobody based chimeric antigen receptor technology for the development and commercialization of iPSC-derived natural killer cells, a promising cellular immunotherapy treatment for cancer and other diseases.
    [Proteintech]

    Press Release

    FEATURED EVENT

    The American Association for Cancer Research (AACR) Annual Meeting 2021

    April 9 – April 14, 2021
    Washington, DC, United States


    > See All Events

    JOB OPPORTUNITIES

    Scientist – Autoimmunity in AML

    Rubius Therapeutics – Cambridge, Massachusetts, United States

    Research
    Scientists – Inflammatory Skin Diseases

    University of Dundee – Dundee, Scotland, United Kingdom

    Senior
    Scientific Researcher – Immunology Discovery

    Genentech, Inc. – South San Francisco, California, United States


    Tier 2 Canada Research Chair – Immunology and Inflammation

    Queen’s University – Kingston, Ontario, Canada

    Research
    Positions – Cancer and Immunotherapy

    Terasaki Research Institute – Los Angeles, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Immune Regulation News
    Archives
    Contact Us
    Immune Regulation News Twitter